Vaccine Regimens For Zaire Ebola Virus Disease Produce Antibody Responses In Adults, Children, Studies Show

Reuters (12/14, Srinivasan, Leo) reports Ebola vaccine regimens targeting the Zaire virus strain “developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two stu...